Lucid Diagnostics (LUCD) Receivables - Other (2020 - 2023)

Lucid Diagnostics (LUCD) has 4 years of Receivables - Other data on file, last reported at $10.7 million in Q2 2023.

• For the quarter ending Q2 2023, Receivables - Other rose 340.39% year-over-year to $10.7 million; the trailing twelve-month figure through Jun 2023 stood at $10.7 million (up 340.39% YoY), and the FY2022 full-year result was $5.0 million, up 199.34% from the prior year.
• Receivables - Other for Q2 2023 stood at $10.7 million, up from $7.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $13.3 million in Q4 2020 and bottomed at $1.7 million in Q4 2021.
• The 4-year median for Receivables - Other is $5.8 million (2022), against an average of $6.1 million.
• The widest annual swing landed in 2021, when Receivables - Other sank 87.5%; it then surged 340.39% in 2023.
• A 4-year view of Receivables - Other shows it stood at $13.3 million in 2020, then tumbled by 87.5% to $1.7 million in 2021, then soared by 199.34% to $5.0 million in 2022, then jumped by 115.67% to $10.7 million in 2023.
• The last three Receivables - Other figures came in at $10.7 million (Q2 2023), $7.6 million (Q1 2023), and $5.0 million (Q4 2022), per Business Quant data.

Peer Comparison